ÂÜÀòÂÒÂ×

Meghan Scanlon has served as a member of the board of directors since April 2022. Ms. Scanlon has served as a Senior Vice President of the Urology and Pelvic Health Division of Boston Scientific Corporation (NYSE: BSX), a medical device company since February 2020. She previously held various leadership positions at Boston Scientific, in global marketing and general management since September 2014. Prior to Boston Scientific, Ms. Scanlon worked at DePuy Synthes, Mitek Sports Medicine, the orthopedics company of Johnson and Johnson from July 2000 to September 2014. These experiences include driving global expansion and product launches, integrating multiple high-growth acquisitions, directing high-impact strategic and portfolio planning, and leading high-performing talent and DEI cultures. Ms. Scanlon holds a B.S in mechanical engineering from Tufts University, and both an M.B.A and an M.S. in Mechanical Engineering from the Massachusetts Institute of Technology.